Published in Future Sci OA on November 30, 2015
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab (1986) 2.81
Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int (2012) 2.74
Vitamin D for cancer prevention: global perspective. Ann Epidemiol (2009) 2.61
Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res (2011) 2.55
Blood biomarkers of vitamin D status. Am J Clin Nutr (2008) 2.53
Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab (2012) 2.41
Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet (1993) 2.27
Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids (2010) 2.19
The extraordinary ligand binding properties of human serum albumin. IUBMB Life (2005) 2.00
The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab (2000) 1.89
Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem (2009) 1.80
A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol (2002) 1.78
Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab (1985) 1.77
Vitamin D and the risk of dementia and Alzheimer disease. Neurology (2014) 1.74
Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab (2013) 1.73
Therapeutic potential of vitamin D-binding protein. Trends Biotechnol (2004) 1.55
Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr (2006) 1.50
Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int (2009) 1.47
A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab (2014) 1.34
Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res (2012) 1.24
Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet (2000) 1.20
Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol (1995) 1.15
Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One (2010) 1.14
Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) (2007) 1.12
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer (2012) 1.06
Measurement of vitamin D status: background, clinical use, and methodologies. Clin Lab (2006) 1.05
Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol (2008) 1.04
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction. Ther Drug Monit (2008) 1.01
Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol (2013) 0.94
Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. PLoS One (2014) 0.91
Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem (2010) 0.89
Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. Ann Pharmacother (1997) 0.89
Vitamin d deficiency and its association with thyroid disease. Int J Health Sci (Qassim) (2013) 0.87
Nutrition: D-iabetes and D-eath D-efying vitamin D. Nat Rev Endocrinol (2012) 0.85
Calculation of normalized drug concentrations in the presence of altered plasma protein binding. Clin Pharmacokinet (2012) 0.84
Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand J Clin Lab Invest (2004) 0.82
Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease. Nutr Neurosci (2013) 0.82
Evidence-based implementation of free phenytoin therapeutic drug monitoring. Clin Chem (2000) 0.82
Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int (2011) 0.80
Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem (2010) 0.80
Overview of extraction methods for analysis of vitamin D and its metabolites in biological samples. Bioanalysis (2011) 0.78
Vitamin D reinvented: implications for clinical chemistry. Clin Chem (2008) 0.76